glp 1 drugs hair loss GLP-1 Medications and Loss: What You Need to Know – Theradome Why some people lose their

The MHRA has issued alerts about falsified semaglutide products in the UK market

Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study

The two types of incretin hormones that have critical roles in incretin signaling, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), bind to specific members of the G-protein-coupled receptor (GPCR) family: the GLP-1 receptor (GLP-1R) and the GIP receptor (GIPR), respectively

The most prevalent factors employers take into consideration for GLP-1 drug coverage for obesity care include: Obesity as a risk factor for chronic conditions and associated costs67% Drug shortages47% Impact/effectiveness of cost-control mechanisms47% Existing coverage through government programs40% Long-term costs33% Patient and prescriber demand33%

Renal Acute Kidney Injury Acute kidney injury is an uncommon but recognized complication of GLP-1 receptor agonists

2025;31(Suppl):S3250